CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

Germline BRCA1/2 mutation (HER2-negative breast cancer)

Gene: BRCA1/BRCA2 · Type: mutation

Indications: Breast cancer

SensitivityResistanceCIViC Context

FDA Sensitivity Assertions

DrugIndicationRecommendationFDA SourceLink
OlaparibBreast cancerINDICATED
FDA Label
Label
TalazoparibBreast cancerINDICATED
FDA Label
Label